We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Rhinomed Limited is a medical devices business based in Australia. Rhinomed shares (RNO) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Rhinomed has a trailing 12-month revenue of around $4.6 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Rhinomed
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Rhinomed. Find the share by name or ticker symbol: RNO. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Rhinomed reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Rhinomed. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Rhinomed stock price (ASX:RNO)Use our graph to track the performance of RNO stocks over time.
Rhinomed shares at a glance
|52-week range||$0.1 - $0.485|
|50-day moving average||$0.324|
|200-day moving average||$0.1899|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.034|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Rhinomed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Rhinomed price performance over time
|1 week (2021-09-17)||2.86%|
|1 month (2021-08-25)||4.35%|
|3 months (2021-06-25)||125.00%|
|6 months (2021-03-25)||188.00%|
|1 year (2020-09-25)||132.26%|
|2 years (2019-09-25)||20.00%|
|3 years (2018-09-25)||33.33%|
|5 years (2016-09-22)||-80.00%|
|Revenue TTM||$4.6 million|
|Gross profit TTM||$3.5 million|
|Return on assets TTM||-55.7%|
|Return on equity TTM||-110.6%|
|Market capitalisation||$88.8 million|
TTM: trailing 12 months
Rhinomed share dividends
We're not expecting Rhinomed to pay a dividend over the next 12 months.
Have Rhinomed's shares ever split?
Rhinomed's shares were split on a 1:10 basis on 2 May 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rhinomed shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Rhinomed shares which in turn could have impacted Rhinomed's share price.
Rhinomed share price volatility
Over the last 12 months, Rhinomed's shares have ranged in value from as little as $0.1 up to $0.485. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Rhinomed's is 0.6391. This would suggest that Rhinomed's shares are less volatile than average (for this exchange).
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; and Pronto for nasal congestion and sleep disturbance issues. It also engages in developing applications for the delivery of medical cannabis and conditions, including anxiety, pain, allergies, nausea, anxiety, and coughs and colds; and nasal swab to test the presence of upper respiratory tract diseases, including influenza, and coronavirus strains. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.
Stocks similar to Rhinomed
Rhinomed in the news
Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children
Rhinomed : Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children
Frequently asked questions
More guides on Finder
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last six months
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Health insurance for podiatry
Find out the steps needed to find adequate cover, and give you an assurance that you won’t have to pay the full cost of your podiatric surgery.
Ask an Expert